来自人类的双歧杆菌分离株中由tet(W)、tet(M)和tet(O)基因介导的四环素抗性
Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans.
作者信息
Aires J, Doucet-Populaire F, Butel M J
机构信息
EA 4065, Laboratory of Microbiology, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris Descartes, 4 Avenue de l'Observatoire, Paris, France.
出版信息
Appl Environ Microbiol. 2007 Apr;73(8):2751-4. doi: 10.1128/AEM.02459-06. Epub 2007 Feb 16.
Abstract
MICs of tetracyclines were determined for 86 human Bifidobacterium isolates and three environmental strains. The tet(O) gene was found to be absent in these isolates. tet(W) and tet(M) were found in 26 and 7%, respectively, of the Bifidobacterium isolates, and one isolate contained both genes. Chromosomal DNA hybridization showed that there was one chromosomal copy of tet(W) and/or tet(M).
摘要
对86株人源双歧杆菌分离株和3株环境菌株测定了四环素的最低抑菌浓度（MIC）。在这些分离株中未发现tet(O)基因。在双歧杆菌分离株中，分别有26%和7%的菌株含有tet(W)和tet(M)，且有一株同时含有这两个基因。染色体DNA杂交显示tet(W)和/或tet(M)有一个染色体拷贝。
相似文献
1
Tetracycline resistance mediated by tet(W), tet(M), and tet(O) genes of Bifidobacterium isolates from humans.
Appl Environ Microbiol. 2007 Apr;73(8):2751-4. doi: 10.1128/AEM.02459-06. Epub 2007 Feb 16.
2
Consecutive human bifidobacteria isolates and acquired tet genes.
Int J Antimicrob Agents. 2009 Mar;33(3):291-3. doi: 10.1016/j.ijantimicag.2008.09.013. Epub 2008 Dec 17.
3
Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans.
Appl Environ Microbiol. 2006 Nov;72(11):7377-9. doi: 10.1128/AEM.00486-06. Epub 2006 Aug 25.
4
Analysis of tetracycline resistance tet(W) genes and their flanking sequences in intestinal Bifidobacterium species.
J Antimicrob Chemother. 2008 Oct;62(4):688-93. doi: 10.1093/jac/dkn280. Epub 2008 Jul 8.
5
Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance.
Antimicrob Agents Chemother. 2004 Sep;48(9):3442-50. doi: 10.1128/AAC.48.9.3442-3450.2004.
6
Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii.
Antimicrob Agents Chemother. 2008 Jan;52(1):248-52. doi: 10.1128/AAC.00714-07. Epub 2007 Oct 29.
7
Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis.
Appl Environ Microbiol. 2010 May;76(10):3364-9. doi: 10.1128/AEM.03096-09. Epub 2010 Mar 26.
8
Analysis of newly detected tetracycline resistance genes and their flanking sequences in human intestinal bifidobacteria.
Sci Rep. 2017 Jul 24;7(1):6267. doi: 10.1038/s41598-017-06595-0.
9
Diverse tetracycline resistance genotypes of Megasphaera elsdenii strains selectively cultured from swine feces.
Appl Environ Microbiol. 2004 Jun;70(6):3754-7. doi: 10.1128/AEM.70.6.3754-3757.2004.
10
Comparative analysis of sequences flanking tet(W) resistance genes in multiple species of gut bacteria.
Antimicrob Agents Chemother. 2006 Aug;50(8):2632-9. doi: 10.1128/AAC.01587-05.
引用本文的文献
1
Complete Genome and Characterization Analysis of a Strain Isolated from Wild Pigs ().
Microorganisms. 2025 Jul 16;13(7):1666. doi: 10.3390/microorganisms13071666.
2
Complexity of antibiotic resistance and its impact on gut microbiota dynamics.
Eng Microbiol. 2024 Dec 30;5(1):100187. doi: 10.1016/j.engmic.2024.100187. eCollection 2025 Mar.
3
Safety and Probiotics Evaluation of Bifidobacterial Genomes Isolated from Probiotic Products.
Curr Microbiol. 2025 Apr 17;82(6):246. doi: 10.1007/s00284-025-04139-8.
4
Probiotics beyond the farm: Benefits, costs, and considerations of using antibiotic alternatives in livestock.
Front Antibiot. 2022 Oct 12;1:1003912. doi: 10.3389/frabi.2022.1003912. eCollection 2022.
5
Exploring the Potential Probiotic Properties of Bifidobacterium breve DSM 32583-A Novel Strain Isolated from Human Milk.
Probiotics Antimicrob Proteins. 2024 Sep 17. doi: 10.1007/s12602-024-10346-9.
6
Simultaneous application of oral and intravaginal probiotics for Helicobacter pylori and its antibiotic-therapy-induced vaginal dysbacteriosis.
NPJ Biofilms Microbiomes. 2024 Jun 20;10(1):49. doi: 10.1038/s41522-024-00521-9.
7
Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.
Probiotics Antimicrob Proteins. 2024 Oct;16(5):1657-1672. doi: 10.1007/s12602-023-10128-9. Epub 2023 Jul 29.
8
Potential of IDCC 4301 isolated from breast milk-fed infant feces as a probiotic and functional ingredient.
Food Sci Nutr. 2023 Feb 8;11(4):1952-1964. doi: 10.1002/fsn3.3230. eCollection 2023 Apr.
9
Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.
Sci Total Environ. 2023 Feb 20;860:160461. doi: 10.1016/j.scitotenv.2022.160461. Epub 2022 Nov 23.
10
Genomic and epigenetic landscapes drive CRISPR-based genome editing in .
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2205068119. doi: 10.1073/pnas.2205068119. Epub 2022 Jul 20.
本文引用的文献
1
Molecular analysis of tet(W) gene-mediated tetracycline resistance in dominant intestinal Bifidobacterium species from healthy humans.
Appl Environ Microbiol. 2006 Nov;72(11):7377-9. doi: 10.1128/AEM.00486-06. Epub 2006 Aug 25.
2
Probiotics and their potential health claims.
Nutr Rev. 2006 Jun;64(6):265-74. doi: 10.1111/j.1753-4887.2006.tb00209.x.
3
Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.
J Antimicrob Chemother. 2006 Jul;58(1):85-94. doi: 10.1093/jac/dkl197. Epub 2006 May 12.
4
Probiotics and their fermented food products are beneficial for health.
J Appl Microbiol. 2006 Jun;100(6):1171-85. doi: 10.1111/j.1365-2672.2006.02963.x.
5
Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food.
Syst Appl Microbiol. 2006 Mar;29(2):145-55. doi: 10.1016/j.syapm.2005.07.009. Epub 2005 Aug 18.
6
Probiotics as functional foods.
Nutr Clin Pract. 2003 Dec;18(6):497-506. doi: 10.1177/0115426503018006497.
7
Macrolide resistance mediated by a Bifidobacterium breve membrane protein.
Antimicrob Agents Chemother. 2005 Oct;49(10):4379-81. doi: 10.1128/AAC.49.10.4379-4381.2005.
8
Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits.
Aliment Pharmacol Ther. 2005 Sep 15;22(6):495-512. doi: 10.1111/j.1365-2036.2005.02615.x.
9
Update on acquired tetracycline resistance genes.
FEMS Microbiol Lett. 2005 Apr 15;245(2):195-203. doi: 10.1016/j.femsle.2005.02.034.
10
The importance of guidelines in the development and application of probiotics.
Curr Pharm Des. 2005;11(1):11-6. doi: 10.2174/1381612053382395.
Zotero 插件